Pharmaceutical French pharma major Sanofi revealed late yesterday that the US Food and Drug Administration (FDA) has approved its Adacel (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed) during the third trimester of pregnancy to help protect against pertussis, or whooping cough, in infants younger than two months of age. 18 January 2023